National and Kapodistrian University of Athens
Η κλινική σημασία της έκφρασης των πρωτεϊνών FAK και c - SRC στα νεοπλάσματα του παγκρέατος
Abstract
dc:descriptionFocal adhesion Kinase (FAK), a member of the Protein Tyrosine Kinases (PTKs)family, is characterised by its subcellular localisation to specialised submembranousstructures called focal adhesions (FAs). Signaling through FAK has been implicated in theregulation of various basic cellular functions. The first interacting molecule in the signalingcascade is another tyrosine kinase, Src. The interaction between FAK and Src results in thefull activation of the first and further the phosphorylation of several enzymes, such as Grb2,PI3K, p130Cas, resulting in the regulation of cellular proliferation, adhesion, survival andmovement in the microenviroment.A number of studies, including ιn vitro and in vivo studies on animal and humancellular lines and tissues, have proven the role of FAK and v-Src, the Rous sarcoma virustransformedhyperactive Src, in the malignant cellular transformation and cancer progress.Recent studies, with encouraging results, are investigating the potential use of FAK and Srcinhibitors as chemotherapeutic agents.Purpose of the studyThe purpose of this study is to investigate the role of the two enzymes specifically inthe pancreatic adenocarcinoma. The immunohistochemical characteristics of the twokinases: expression, intesity and overexpression of staining, were investigated for potentialcorrelations with clinicopathological parameters of the sample, such as patients' age andgender, tumours' stage, grade and proliferation index (Ki-67).Clinical sample and methodsThe sample was consisted of 65 surgically excised pancreatic adenocarcinomaspecimens. The mean age of the patients was 65.68 ± 9.42 years (range 43-84 years).Follow-up was until death. The histological specimens were examined with conventionalimmunohistochemistry techniques. Potential correlations between the stainingcharacteristics of the two enzymes and the sample's clinicopathological parameters wereinvestigated with the use of the appropriate statistical test. Furthermore, statistical models~ 30 ~were constructed aiming to predict clinicopathological characteristics based on theenzymatic staining characteristics.Results• Tumours with increased (moderate and intense) intensity of FAK immunostaining are3.4times more likely in patients younger than 65 years of age (OR=3.375, CI=1.163-9.792,p=0.025).• A trend was identified between patient's gender and the intesity of Src immunostaining(p=0.098). Tumours with increased (moderate and intense) staining intensity were 6 timesmore likely in female patients (OR=6.123, CI=2.031-18,460, p=0.001).• Tumours' grade significantly correlated with FAK expression (p=0,020). More specifically,increased FAK staining intensity was identified as an independent prognostic factor fortumours' grade (OR=8.593, CI=1.007-73.319, p=0.049). Tumours with low (absent orweak) intensity levels were 13.3 times more likely to be of low grade (grade 1)(OR=13.333, CI=1.069-166.374, p=0.044).• A trend was identified between AJCC stage and FAK overexpression (p=0.053). AJCCstage was significantly correlated with Src overexpression (p=0.014), with more stage Iand II tumours overexpressing the kinase, being also an independent prognostic factor(OR=7, CI=1.3-37.704, p=0.024 for stage III neoplasms).• A trend was reported between T stage and the overexpression of both FAK (p=0.113) andSrc (p=0.130).• M stage was significantly correlated with FAK expression (p=0.004), with all M1 tumoursexpressing the enzyme, while a significant portion of the M0 ones being negative.• M stage was significantly correlated with the intensity of FAK immunostaining (p=0.003),with all M1 tumours presenting weak intensity of staining, in contrast to M0 ones, which inhigher proportion presented moderate intensity.• A trend was discovered betwewen M stage and FAK (p=0.107) and Src overexpression(p=0.098).• A trend was identified between longer patients' survival and Src expression (p=0.119) andincreased intensity of immunostaining (p=0.162).~ 31 ~• Longer survival was significantly correlated with Src overexression (p=0.027), withpatients suffering from tumours that did not present Src overexpression being at about1.7 times higher risk for reduced survival (HR= 1.674, CI= 1.003-2.795, p=0.049).ConclusionsThis study has identified significant correlations between the staining characteristics ofthe two enzymes and clinicopathological parameters of patients with pancreaticadenocarcinoma. In this way, along with a small number of published evidence, our effortapproached the clinical significance of the two kinases in the pathophysiology of pancreaticadenocarcinoma, sup[porting the value and significance of research efforts in the field ofstudying FAK and Src inhibitors as chemotherapeutic agents for pancreatic cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chatzizacharias, Nikolaos
- Χατζηζαχαριάς, Νικόλαος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29682